Tags

Type your tag names separated by a space and hit enter

Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.

Abstract

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death globally. In addition to the mortality associated with it, people with COPD experience significant morbidity, making this set of conditions a major public health concern. Infections caused by influenza virus are a preventable cause of morbidity and vaccination has been shown to be effective. The evidence of their benefit in persons with COPD mainly comes from high-income countries where influenza vaccination is used in routine practice, but little is known about the effectiveness, cost-effectiveness, and scalability of vaccination in low- and middle-income countries. We therefore systematically reviewed and present evidence related to vaccination against influenza in persons with COPD with a special focus on studies from low- and middle-income countries (LMICs). Available data from 19 studies suggest that the use of influenza vaccine in persons with COPD is beneficial, cost-effective, and may be relevant for low- and middle-income countries. Wider implementation of this intervention needs to take into account the health care delivery systems of LMICs and use of prevalent viral strains in vaccines to be most cost effective.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    a Institute of Public Health , Bengaluru , India.

    ,

    b Rollins School of Public Health , Emory University , Atlanta , Georgia , USA.

    ,

    c Emory University School of Medicine , Atlanta , Georgia , USA.

    ,

    a Institute of Public Health , Bengaluru , India.

    b Rollins School of Public Health , Emory University , Atlanta , Georgia , USA.

    Source

    COPD 13:1 2016 pg 93-9

    MeSH

    Cost-Benefit Analysis
    Developing Countries
    Disease Management
    Humans
    Influenza Vaccines
    Influenza, Human
    Pulmonary Disease, Chronic Obstructive
    Treatment Outcome

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    26418892

    Citation

    Lall, Dorothy, et al. "Effectiveness of Influenza Vaccination for Individuals With Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries." COPD, vol. 13, no. 1, 2016, pp. 93-9.
    Lall D, Cason E, Pasquel FJ, et al. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. COPD. 2016;13(1):93-9.
    Lall, D., Cason, E., Pasquel, F. J., Ali, M. K., & Narayan, K. M. (2016). Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. COPD, 13(1), pp. 93-9. doi:10.3109/15412555.2015.1043518.
    Lall D, et al. Effectiveness of Influenza Vaccination for Individuals With Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. COPD. 2016;13(1):93-9. PubMed PMID: 26418892.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. AU - Lall,Dorothy, AU - Cason,E, AU - Pasquel,F J, AU - Ali,M K, AU - Narayan,K M V, Y1 - 2015/09/29/ PY - 2015/9/30/entrez PY - 2015/9/30/pubmed PY - 2016/10/19/medline KW - Chronic Obstructive Pulmonary Disease (COPD) KW - effectiveness KW - influenza vaccine KW - low and middle income countries SP - 93 EP - 9 JF - COPD JO - COPD VL - 13 IS - 1 N2 - Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death globally. In addition to the mortality associated with it, people with COPD experience significant morbidity, making this set of conditions a major public health concern. Infections caused by influenza virus are a preventable cause of morbidity and vaccination has been shown to be effective. The evidence of their benefit in persons with COPD mainly comes from high-income countries where influenza vaccination is used in routine practice, but little is known about the effectiveness, cost-effectiveness, and scalability of vaccination in low- and middle-income countries. We therefore systematically reviewed and present evidence related to vaccination against influenza in persons with COPD with a special focus on studies from low- and middle-income countries (LMICs). Available data from 19 studies suggest that the use of influenza vaccine in persons with COPD is beneficial, cost-effective, and may be relevant for low- and middle-income countries. Wider implementation of this intervention needs to take into account the health care delivery systems of LMICs and use of prevalent viral strains in vaccines to be most cost effective. SN - 1541-2563 UR - https://www.unboundmedicine.com/medline/citation/26418892/Effectiveness_of_Influenza_Vaccination_for_Individuals_with_Chronic_Obstructive_Pulmonary_Disease__COPD__in_Low__and_Middle_Income_Countries_ L2 - http://www.tandfonline.com/doi/full/10.3109/15412555.2015.1043518 DB - PRIME DP - Unbound Medicine ER -